• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

超急性移植物抗宿主病对异基因干细胞移植结果的临床影响。

Clinical impact of hyperacute graft-versus-host disease on results of allogeneic stem cell transplantation.

作者信息

Kim D H, Sohn S K, Kim J G, Suh J S, Lee K S, Lee K B

机构信息

Department of Hematology/Oncology, Kyungpook National University Hospital, 50 Samduk 2-Ga, Jung-Gu, Daegu 700-721, Korea.

出版信息

Bone Marrow Transplant. 2004 May;33(10):1025-30. doi: 10.1038/sj.bmt.1704479.

DOI:10.1038/sj.bmt.1704479
PMID:15064689
Abstract

The current study defines the incidence and clinical manifestations of hyperacute graft-versus-host disease (haGVHD; fever, skin rash, diarrhea, and hepatic dysfunction) and analyzes the risk factor and the impact of haGVHD on the results of allogeneic stem cell transplantation (SCT). In all, 90 patients underwent allogeneic SCT from 71 matched siblings or 19 alternative donors. Immediate high-dose steroids were administered to 22 patients who met the criteria. The overall incidence of haGVHD was 36.7% (n=34) and haGVHD was also strongly correlated with acute (aGVHD) (P<0.001) and extensive chronic GVHD (cGVHD) (P=0.007), and found to be associated with decreased probability of relapse (P=0.0017). Early intervention with steroids within 7 days after the diagnosis of haGVHD might be associated with better survival. A survival analysis of the overall survival and disease-free survival did not reveal any difference between haGVHD+ and haGVHD- groups. In multivariate analysis, the use of an alternative donor (P=0.020) was identified as the only risk factor. Immediate high-dose steroids were effective in treating haGVHD. We conclude that in an allogeneic setting, haGVHD is not an uncommon manifestation, associated with the development of aGVHD or cGVHD. The only risk factor for haGVHD was the use of an alternative donor.

摘要

本研究定义了超急性移植物抗宿主病(haGVHD;发热、皮疹、腹泻和肝功能障碍)的发病率及临床表现,并分析了其危险因素以及haGVHD对异基因干细胞移植(SCT)结果的影响。共有90例患者接受了来自71名匹配同胞或19名替代供者的异基因SCT。对符合标准的22例患者立即给予大剂量类固醇治疗。haGVHD的总体发病率为36.7%(n = 34),且haGVHD还与急性移植物抗宿主病(aGVHD)(P < 0.001)和广泛慢性移植物抗宿主病(cGVHD)(P = 0.007)密切相关,同时发现其与复发概率降低相关(P = 0.0017)。在诊断haGVHD后7天内早期使用类固醇干预可能与更好的生存率相关。对总生存期和无病生存期的生存分析未显示haGVHD阳性组和阴性组之间存在任何差异。在多变量分析中,使用替代供者(P = 0.020)被确定为唯一的危险因素。立即给予大剂量类固醇治疗haGVHD有效。我们得出结论,在异基因移植环境中,haGVHD并非罕见表现,与aGVHD或cGVHD的发生相关。haGVHD的唯一危险因素是使用替代供者。

相似文献

1
Clinical impact of hyperacute graft-versus-host disease on results of allogeneic stem cell transplantation.超急性移植物抗宿主病对异基因干细胞移植结果的临床影响。
Bone Marrow Transplant. 2004 May;33(10):1025-30. doi: 10.1038/sj.bmt.1704479.
2
Risk-factor analysis for predicting progressive- or quiescent-type chronic graft-versus-host disease in a patient cohort with a history of acute graft-versus-host disease after allogeneic stem cell transplantation.对异基因干细胞移植后有急性移植物抗宿主病病史的患者队列中预测进展型或静止型慢性移植物抗宿主病的危险因素分析。
Bone Marrow Transplant. 2006 Apr;37(7):699-708. doi: 10.1038/sj.bmt.1705313.
3
Impact of human leucocyte antigen mismatch on graft-versus-host disease and graft failure after reduced intensity conditioning allogeneic haematopoietic stem cell transplantation from related donors.人类白细胞抗原错配对来自相关供体的减低强度预处理异基因造血干细胞移植后移植物抗宿主病和移植物失败的影响。
Br J Haematol. 2005 Aug;130(4):575-87. doi: 10.1111/j.1365-2141.2005.05632.x.
4
Long-term outcome of myeloablative allogeneic stem cell transplantation for multiple myeloma.多发性骨髓瘤清髓性异基因干细胞移植的长期疗效
Biol Blood Marrow Transplant. 2007 Aug;13(8):925-31. doi: 10.1016/j.bbmt.2007.04.006. Epub 2007 May 29.
5
Successful prevention of acute graft-versus-host disease using low-dose antithymocyte globulin after mismatched, unrelated, hematopoietic stem cell transplantation for acute myelogenous leukemia.在急性髓系白血病患者接受不匹配、非亲属造血干细胞移植后,使用低剂量抗胸腺细胞球蛋白成功预防急性移植物抗宿主病。
Biol Blood Marrow Transplant. 2009 Jun;15(6):704-17. doi: 10.1016/j.bbmt.2009.02.010. Epub 2009 Apr 9.
6
Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.异基因反应性作为血液系统恶性肿瘤治疗的治疗原则。非清髓性预处理的异基因造血细胞移植的临床和免疫学方面的研究。
Dan Med Bull. 2007 May;54(2):112-39.
7
Prognostic factors of chronic graft-versus-host disease after allogeneic blood stem-cell transplantation.异基因造血干细胞移植后慢性移植物抗宿主病的预后因素
Am J Hematol. 2005 Apr;78(4):265-74. doi: 10.1002/ajh.20275.
8
Risk assessment and outcome of chronic graft-versus-host disease after allogeneic peripheral blood progenitor cell transplantation in pediatric patients.儿童患者异基因外周血造血干细胞移植后慢性移植物抗宿主病的风险评估及结局
Bone Marrow Transplant. 2004 Sep;34(5):433-8. doi: 10.1038/sj.bmt.1704589.
9
Clinical impact of graft-versus-host disease against leukemias not in remission at the time of allogeneic hematopoietic stem cell transplantation from related donors. The Japan Society for Hematopoietic Cell Transplantation Working Party.来自相关供体的异基因造血干细胞移植时,移植物抗宿主病对未缓解白血病的临床影响。日本造血细胞移植学会工作组。
Bone Marrow Transplant. 2004 Oct;34(8):711-9. doi: 10.1038/sj.bmt.1704659.
10
Clinical relevance of NK, NKT, and dendritic cell dose in patients receiving G-CSF-mobilized peripheral blood allogeneic stem cell transplantation.接受粒细胞集落刺激因子动员的外周血异基因干细胞移植患者中自然杀伤细胞、自然杀伤T细胞和树突状细胞剂量的临床相关性
Ann Hematol. 2006 Feb;85(2):113-20. doi: 10.1007/s00277-005-0037-5. Epub 2005 Nov 26.

引用本文的文献

1
Graft-Versus-Host Disease Mouse Models: A Clinical-Translational Perspective.移植物抗宿主病小鼠模型:临床转化视角
Methods Mol Biol. 2025;2907:1-56. doi: 10.1007/978-1-0716-4430-0_1.
2
Hyperacute Graft-Versus-Host Disease of the Skin following Allogeneic Stem Cell Transplantation: A Paediatric Case Series.异基因干细胞移植后皮肤超急性移植物抗宿主病:一组儿科病例
Indian J Dermatol. 2023 Jan-Feb;68(1):73-77. doi: 10.4103/ijd.ijd_503_22.
3
Future Perspectives in Small-Diameter Vascular Graft Engineering.小直径血管移植工程的未来展望
Bioengineering (Basel). 2020 Dec 10;7(4):160. doi: 10.3390/bioengineering7040160.
4
Pre-engraftment syndrome: clinical significance and pathophysiology.植入前综合征:临床意义与病理生理学
Blood Res. 2016 Sep;51(3):152-154. doi: 10.5045/br.2016.51.3.152. Epub 2016 Sep 23.
5
Engraftment syndrome: double-edged sword of hematopoietic cell transplants.植入综合征:造血细胞移植的双刃剑
Bone Marrow Transplant. 2015 Apr;50(4):469-75. doi: 10.1038/bmt.2014.296. Epub 2015 Jan 12.
6
Engraftment syndrome after allogeneic hematopoietic cell transplantation predicts poor outcomes.异基因造血细胞移植后的植入综合征预示着不良预后。
Biol Blood Marrow Transplant. 2014 Sep;20(9):1407-17. doi: 10.1016/j.bbmt.2014.05.022. Epub 2014 Jun 2.
7
Invasive fungal infections in acute leukemia.急性白血病的侵袭性真菌感染。
Ther Adv Hematol. 2011 Aug;2(4):231-47. doi: 10.1177/2040620711410098.
8
The impact of early CD4+ lymphocyte recovery on the outcome of patients who undergo allogeneic bone marrow or peripheral blood stem cell transplantation.早期 CD4+ 淋巴细胞恢复对接受异基因骨髓或外周血干细胞移植患者结局的影响。
Blood Transfus. 2012 Apr;10(2):174-80. doi: 10.2450/2012.0034-11. Epub 2012 Jan 24.